AC BioScience Ltd is a pre-clinical stage biotechnology company dedicated to developing innovative therapies for the treatment of tumoral and immunological pathologies.

Products, services, technology

ACB2112, a molecule in the Azole group, enhances the efficacy of checkpoint-inhibitor immune-therapy. Outstanding results found in reducing tumor burden in the CT26 model for CRC.

Location
Additional address info
  • c/o Biopôle, Building 'Lysine'
Canton
Facts & figures
  • Type of organization
    Private company
  • Year of foundation
    2017
  • Number of employees in Switzerland
    1-9
Key business

You may also be interested in